Amid this surge, Novo Nordisk, the company behind GLP-1 drugs Ozempic and Wegovy, has experienced a remarkable rise in its stock price, from roughly $50 per share in 2022 to upwards of $142 in June 2024
When ill and at risk of dehydration, people with T2DM should be advised to: Temporarily stop SADMANS drugs ( S GLT2is, A CEis, D iuretics [individualise in those with HF], M etformin, A RBs, N SAIDs and S ulfonylureas*), and if unable to eat or drink, or persistent vomiting or diarrhoea, to contact their GP or specialist nurse for advice
Conclusions: GLP-1RAs have a broad spectrum of dermatologic effects, from immunomodulatory benefits to adverse cutaneous reactions
(26) In a follow-up study, Werkman et al